Keyword Filter
Development of a Th1-Polarizing Dendritic Cell Vaccine Driving Cytotoxic T-Lymphocyte-Mediated Killing of Autologous Breast Cancer Cells in vitro [POSTER PRESENTATION] iconDevelopment of a Th1-Polarizing Dendritic Cell Vaccine Driving Cytotoxic T-Lymphocyte-Mediated Killing of Autologous Breast Cancer Cells in vitro [POSTER PRESENTATION]

Development of a Th1-Polarizing Dendritic Cell Vaccine Driving Cytotoxic T-Lymphocyte-Mediated Killing of Autologous Breast Cancer Cells in vitro [POSTER PRESENTATION]

Recorded during the Keystone Symposia meeting:



Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology



Mar 19 - Mar 23, 2017 | Whistler, British Columbia, Canada

Arginase Is an Immunosuppressive Enzyme [POSTER PRESENTATION] iconArginase Is an Immunosuppressive Enzyme [POSTER PRESENTATION]

Arginase Is an Immunosuppressive Enzyme [POSTER PRESENTATION]

Recorded during the Keystone Symposia meeting:

Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology

Mar 19 - Mar 23, 2017 | Whistler, British Columbia, Canada

Βeta-Alethine, an Immunostimulatory Drug that Synergizes with Anti-PD1 Therapy [POSTER PRESENTATION] iconΒeta-Alethine, an Immunostimulatory Drug that Synergizes with Anti-PD1 Therapy [POSTER PRESENTATION]

Βeta-Alethine, an Immunostimulatory Drug that Synergizes with Anti-PD1 Therapy [POSTER PRESENTATION]

Recorded during the Keystone Symposia meeting:



Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology



Mar 19 - Mar 23, 2017 | Whistler, British Columbia, Canada

Humanized Mouse: A Model for Understanding Tumor-Immune System Interactions [SHORT TALK] iconHumanized Mouse: A Model for Understanding Tumor-Immune System Interactions [SHORT TALK]

Humanized Mouse: A Model for Understanding Tumor-Immune System Interactions [SHORT TALK]

Recorded during the Keystone Symposia meeting:



Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology



Mar 19 - Mar 23, 2017 | Whistler, British Columbia, Canada

Personalized Neoantigen-Specific Adoptive T Cell Therapy for AML and MDS [SHORT TALK] iconPersonalized Neoantigen-Specific Adoptive T Cell Therapy for AML and MDS [SHORT TALK]

Personalized Neoantigen-Specific Adoptive T Cell Therapy for AML and MDS [SHORT TALK]

Recorded during the Keystone Symposia meeting:



Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology



Mar 19 - Mar 23, 2017 | Whistler, British Columbia, Canada

Effective T Cell Activation in Invaded Lymph Nodes from Breast Cancer Patients [POSTER PRESENTATION] iconEffective T Cell Activation in Invaded Lymph Nodes from Breast Cancer Patients [POSTER PRESENTATION]

Effective T Cell Activation in Invaded Lymph Nodes from Breast Cancer Patients [POSTER PRESENTATION]

Recorded during the Keystone Symposia meeting:



Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology



Mar 19 - Mar 23, 2017 | Whistler, British Columbia, Canada

Targeting Ezh2 Selectively Alters Intratumoral T Regulatory Cells to Enhance Cancer Immunity [POSTER PRESENTATION] iconTargeting Ezh2 Selectively Alters Intratumoral T Regulatory Cells to Enhance Cancer Immunity [POSTER PRESENTATION]

Targeting Ezh2 Selectively Alters Intratumoral T Regulatory Cells to Enhance Cancer Immunity [POSTER PRESENTATION]

Recorded during the Keystone Symposia meeting:



Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology



Mar 19 - Mar 23, 2017 | Whistler, British Columbia, Canada

Chemerin, a Leukocyte Chemoattractant, Upregulates PTEN via CMKLR1 in Human Tumors [POSTER PRESENTATION] iconChemerin, a Leukocyte Chemoattractant, Upregulates PTEN via CMKLR1 in Human Tumors [POSTER PRESENTATION]

Chemerin, a Leukocyte Chemoattractant, Upregulates PTEN via CMKLR1 in Human Tumors [POSTER PRESENTATION]

Recorded during the Keystone Symposia meeting:



Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology



Mar 19 - Mar 23, 2017 | Whistler, British Columbia, Canada

Targeting TNF-α and IFN-γ to Tumor Vessels Confer Efficacy to Adoptive T cell Therapy [POSTER PRESENTATION] iconTargeting TNF-α and IFN-γ to Tumor Vessels Confer Efficacy to Adoptive T cell Therapy [POSTER PRESENTATION]

Targeting TNF-α and IFN-γ to Tumor Vessels Confer Efficacy to Adoptive T cell Therapy [POSTER PRESENTATION]

Recorded during the Keystone Symposia meeting:



Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology



Mar 19 - Mar 23, 2017 | Whistler, British Columbia, Canada

Broadening the Immunotherapeutic Window of Cancers with Low Mutational Loads using Subclinical Doses of Radiation [POSTER PRESENTATION] iconBroadening the Immunotherapeutic Window of Cancers with Low Mutational Loads using Subclinical Doses of Radiation [POSTER PRESENTATION]

Broadening the Immunotherapeutic Window of Cancers with Low Mutational Loads using Subclinical Doses of Radiation [POSTER PRESENTATION]

Recorded during the Keystone Symposia meeting:



Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology



Mar 19 - Mar 23, 2017 | Whistler, British Columbia, Canada